264 related articles for article (PubMed ID: 1743611)
1. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
Inoue K; Hisatomi A; Umeda F; Nawata H
Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
[TBL] [Abstract][Full Text] [Related]
2. Carbachol priming increases glucose- and glucagon-like peptide-1 (7-36)amide-, but not arginine-induced insulin secretion from the isolated perfused rat pancreas.
Fehmann HC; Göke R; Göke B; Arnold R
Z Gastroenterol; 1990 Jul; 28(7):348-52. PubMed ID: 2238765
[TBL] [Abstract][Full Text] [Related]
3. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas.
Schmid R; Schusdziarra V; Aulehner R; Weigert N; Classen M
Z Gastroenterol; 1990 Jun; 28(6):280-4. PubMed ID: 2238756
[TBL] [Abstract][Full Text] [Related]
4. Release of amylin from perfused rat pancreas in response to glucose and glucagon.
Inoue K; Hisatomi A; Umeda F; Nawata H
Diabetes Res Clin Pract; 1992 Jan; 15(1):85-8. PubMed ID: 1541239
[TBL] [Abstract][Full Text] [Related]
5. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Yamashita K
Endocrinology; 1989 Dec; 125(6):3109-14. PubMed ID: 2684616
[TBL] [Abstract][Full Text] [Related]
7. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
9. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach.
Lippl F; Kircher F; Erdmann J; Allescher HD; Schusdziarra V
Regul Pept; 2004 Jun; 119(1-2):93-8. PubMed ID: 15093702
[TBL] [Abstract][Full Text] [Related]
10. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
Hashiguchi S; Yada T; Arima T
J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K
Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338
[TBL] [Abstract][Full Text] [Related]
12. Total parenteral nutrition-stimulated activity of inducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1.
Salehi A; Ekelund M; Lundquist I
Horm Metab Res; 2003 Jan; 35(1):48-54. PubMed ID: 12669271
[TBL] [Abstract][Full Text] [Related]
13. Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas.
Göke R; Wagner B; Fehmann HC; Göke B
Res Exp Med (Berl); 1993; 193(2):97-103. PubMed ID: 8516568
[TBL] [Abstract][Full Text] [Related]
14. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide.
Komatsu R; Matsuyama T; Namba M; Watanabe N; Itoh H; Kono N; Tarui S
Diabetes; 1989 Jul; 38(7):902-5. PubMed ID: 2661287
[TBL] [Abstract][Full Text] [Related]
15. Effects of exogenous somatostatin and insulin on islet amyloid polypeptide (amylin) release from perfused rat pancreas.
Inoue K; Hisatomi A; Umeda F; Nawata H
Horm Metab Res; 1992 Jun; 24(6):251-3. PubMed ID: 1353050
[TBL] [Abstract][Full Text] [Related]
16. Glucagonlike peptide I (7-37) actions on endocrine pancreas.
Weir GC; Mojsov S; Hendrick GK; Habener JF
Diabetes; 1989 Mar; 38(3):338-42. PubMed ID: 2645190
[TBL] [Abstract][Full Text] [Related]
17. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941
[TBL] [Abstract][Full Text] [Related]
18. Interaction of glucagon-like peptide-1(7-36)amide and somatostatin-14 in RINm5F cells and in the perfused rat pancreas.
Göke R; Fehmann HC; Richter G; Trautmann M; Göke B
Pancreas; 1989; 4(6):668-73. PubMed ID: 2573056
[TBL] [Abstract][Full Text] [Related]
19. Developmental patterns of glucagon-like peptide-1-(7-36) amide and peptide-YY in rat pancreas and gut.
Kreymann B; Ghatei MA; Domin J; Kanse S; Bloom SR
Endocrinology; 1991 Aug; 129(2):1001-5. PubMed ID: 1677327
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro.
Guenifi A; Ahrén B; Abdel-Halim SM
Pancreas; 2001 Jan; 22(1):58-64. PubMed ID: 11138972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
